Michael McMyne

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Steinway Musical Instruments, Inc. was designed, manufactured and marketed musical instruments. The firm offered pianos, band and orchestral Instruments. The company was founded in 1993 and was headquartered in New York, NY.

Jumo Health, Inc. operates as a children’s health education company which produces health content for children and families. The firms products allow children, families, and caregivers to learn and better manage their condition through podcasts, videos, games, and more. The company was founded by Kim Chilman-Blair and Kate Hersov in 2009 and is headquartered in New York, NY.

Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC.

The Metropolitan Museum of Art operates as an arts institution that maintains a museum and library of art, encouraging and developing the study of the fine arts, and the application of arts to manufacture and practical life. The company was founded in 1870 and is headquartered in New York, NY.

Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ.

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

The Partnership for New York City operates as a charitable organization. It is a network of business leaders and corporations working for the economic and cultural betterment of all five boroughs of the city. The firm provides networking opportunities, conducts research, participates in policy making and lobbies government. The company was founded by David Rockefeller in 2002 and is headquartered in New York, NY.

The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC.

The Economic Club of New York operates as a nonprofit, nonpartisan and nonpolitical organization. The company was founded by J.W. Beatson in 1907 and is headquartered in New York, NY.

Central Park Conservancy, Inc. maintains and develops the Central Park. It offer lawns pruning, trees fertilization, shrubs and flowers plantation, ball fields and playgrounds maintenance, graffiti removing, and monuments conservation. The firm also provides water bodies and woodlands sanitation, erosion control, drainage cleanliness, pollution control, and salvation prevention services. The company was founded in 1980 and is headquartered in New York, NY.

Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.

Manhattan Institute For Policy Research, Inc. develops and disseminate new ideas for greater economic choice and individual responsibility. It focuses on economic growth, education, energy and environment, health care, legal reform, public sector, race and urban policy. The company was founded by Antony Fisher and William J. Casey in 1977 and is headquartered in New York, NY.

92nd Street Young Men's & Young Women's Hebrew Association offers Jewish arts, culture, life, education and other programs. It is a Jewish institution that reaches out to people of every race, ethnicity, religion, age and economic class. The firm seeks to create, provide and disseminate programs of distinction that foster the physical and mental health of human beings throughout their lives, their educational and spiritual growth and their enjoyment. The company was founded on March 22, 1874 and is headquartered in New York, NY.

Steinway Musical Instruments Holdings, Inc. manufacturers musical instruments. It segments includes piano segment and Band segment The company was founded by Henry Engelhard in 1853 and is headquartered in New York, NY.

Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.

Eshelman Ventures LLC (Eshelman Ventures) is a venture capital firm founded in 2014 by Fredric N. Eshelman. The firm is headquartered in Wilmington, North Carolina.

Paulson European Opportunities Fund Ltd. operates as a pooled investment fund. The company is headquartered in Grand Cayman, Cayman Islands.

Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC.

Paulson & Co Inc. (Private Equity) (Paulson & Co) is a private equity subsidiary of Paulson & Co Inc founded in 1994. The firm is headquartered in New York.

Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation.

Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.